Trademark Overview
On Friday, February 9, 2024, a trademark application was filed for CALLAVID with the United States Patent and Trademark Office. The USPTO has given the CALLAVID trademark a serial number of 79401819. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, March 13, 2025. This trademark is owned by Calla Lily Clinical Care Ltd. The CALLAVID trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical and medical preparations for use in the area of the vagina; sanitary preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical preparations including probiotics for medicinal use; drug delivery agents for use in the vagina that facilitate the delivery of pharmaceutical preparations including probiotics for medicinal use; absorbent sanitary articles being sanitary pads, tampons or a combination of the two; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer; moisturisers, gels, creams and pessaries for use within and in the area of the vagina, all for medical purposes
medical apparatus and instruments for use in gynecological medicine; Pre-loaded intra-vaginal apparatus for administering lubricants, moisturisers, gels, creams and pessaries; intra-vaginal pessaries being pre-loaded vaginal drug delivery devices for administering medications and therapeutics; intra-vaginal pessaries being vaginal drug delivery devices sold pre-loaded with therapeutic preparations for use in pregnancy loss and prevention; intra-vaginal pessaries being vaginal drug delivery devices sold pre-loaded with therapeutic preparations for use in IVF; intra-vaginal pessaries being vaginal drug delivery devices sold pre-loaded with therapeutic preparations for use in menopause; intra-vaginal pessaries being vaginal drug delivery devices sold pre-loaded with therapeutic preparations for the treatment of cancer; Delivery devices sold pre-loaded with probiotics for administration into the vagina; intra-vaginal pessaries being vaginal drug delivery devices sold preloaded with therape...
